Showing results (821-830 of 3,181) with videos related to

Sort By:
Pageof 319
Molecular Cancer Research : MCR|January 11, 2012
WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathwayShin Yoshioka, Mandy L King, Sophia Ran, et al.
Molecular Cancer Research : MCR|January 11, 2012
In situ analysis of mutant EGFRs prevalent in glioblastoma multiforme reveals aberrant dimerization, activation, and differential response to anti-EGFR targeted therapyAaron S Gajadhar, Elena Bogdanovic, Diana Marcela Muñoz, et al.
Molecular Cancer Research : MCR|January 14, 2012
Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotypeJeena Joseph, Yusuke Shiozawa, Younghun Jung, et al.
Molecular Cancer Research : MCR|January 14, 2012
The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migrationChiang-Yen Chiu, Kung-Kai Kuo, Tzu-Lei Kuo, et al.
Molecular Cancer Research : MCR|March 29, 2012
Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycinReema S Wahdan-Alaswad, Kara L Bane, Kyung Song, et al.
Molecular Cancer Research : MCR|April 1, 2011
Mucin 13: structure, function, and potential roles in cancer pathogenesisDiane M Maher, Brij K Gupta, Satoshi Nagata, et al.
Molecular Cancer Research : MCR|April 5, 2011
MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinibMarta Albajar, M Teresa Gómez-Casares, Javier Llorca, et al.
Molecular Cancer Research : MCR|April 5, 2011
Vinculin activators target integrins from within the cell to increase melanoma sensitivity to chemotherapyElke S Nelson, Andrew W Folkmann, Michael D Henry, et al.
Molecular Cancer Research : MCR|April 16, 2011
Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cellsJoanna Bialek, Usakorn Kunanuvat, Sabine Hombach-Klonisch, et al.
Molecular Cancer Research : MCR|June 25, 2011
TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cellsAlfiya Safina, Paula Sotomayor, Michelle Limoge, et al.
Pageof 319